Related Articles
In vitro neutralization of autocrine IL‑10 affects Op18/stathmin signaling in non‑small cell lung cancer cells
Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin
The Cdc2/Cdk1 inhibitor, purvalanol A, enhances the cytotoxic effects of taxol through Op18/stathmin in non-small cell lung cancer cells in vitro
An underlying prognosis predictor of hepatocellular carcinoma: Oncoprotein 18
CELL-TYPE-SPECIFIC REGULATION OF P53 EXPRESSION IN NONSMALL CELL LUNG-CARCINOMA CELLS